{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T16:12:58Z","timestamp":1773677578829,"version":"3.50.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1016\/j.bbrc.2011.02.117","type":"journal-article","created":{"date-parts":[[2011,3,7]],"date-time":"2011-03-07T14:02:50Z","timestamp":1299506570000},"page":"103-107","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Crystallizing nanoparticles derived from vascular smooth muscle cells contain the calcification inhibitor osteoprotegerin"],"prefix":"10.1016","volume":"407","author":[{"given":"Michael","family":"Schoppet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary M.","family":"Kavurma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenz C.","family":"Hofbauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine M.","family":"Shanahan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2011.02.117_b0005","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1001\/jama.292.4.490","article-title":"Clinical implications of the osteoprotegerin\/RANKL\/RANK system for bone and vascular diseases","volume":"2924","author":"Hofbauer","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.bbrc.2011.02.117_b0010","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1101\/gad.12.9.1260","article-title":"Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification","volume":"12","author":"Bucay","year":"1998","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbrc.2011.02.117_b0015","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1161\/CIRCRESAHA.108.189001","article-title":"RANKL increases vascular smooth muscle cell calcification through a RANK-BMP4-dependent pathway","volume":"104","author":"Panizo","year":"2009","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbrc.2011.02.117_b0020","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1161\/CIRCRESAHA.110.216846","article-title":"Estrogen inhibits vascular calcification via vascular RANKL system: common mechanism of osteoporosis and vascular calcification","volume":"107","author":"Osako","year":"2010","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbrc.2011.02.117_b0025","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1161\/hq1001.097102","article-title":"Osteoprotegerin inhibits artery calcification induced by warfarin and by vitamin D","volume":"21","author":"Price","year":"2001","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbrc.2011.02.117_b0030","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1161\/CIRCULATIONAHA.107.707380","article-title":"Osteoprotegerin inhibits vascular calcification without affecting atherosclerosis in ldlr(\u2212\/\u2212) mice","volume":"117","author":"Morony","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.bbrc.2011.02.117_b0035","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1161\/01.ATV.0000236428.91125.e6","article-title":"Osteoprotegerin inactivation accelerates advanced atherosclerotic lesion progression and calcification in older ApoE\u2212\/\u2212 mice","volume":"26","author":"Bennett","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbrc.2011.02.117_b0040","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1210\/jc.2002-020775","article-title":"Increased osteoprotegerin serum levels in men with coronary artery disease","volume":"88","author":"Schoppet","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbrc.2011.02.117_b0045","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1161\/01.CIR.0000031524.49139.29","article-title":"Serum osteoprotegerin levels are associated with the presence and severity of coronary artery disease","volume":"106","author":"Jono","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.bbrc.2011.02.117_b0050","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1161\/01.CIR.0000127957.43874.BB","article-title":"Osteoprotegerin is a risk factor for progressive atherosclerosis and cardiovascular disease","volume":"109","author":"Kiechl","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.bbrc.2011.02.117_b0055","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1053\/ajkd.2002.31402","article-title":"Increased circulating levels of osteoclastogenesis inhibitory factor (osteoprotegerin) in patients with chronic renal failure","volume":"39","author":"Kazama","year":"2002","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.bbrc.2011.02.117_b0060","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1159\/000257339","article-title":"Human full-length osteoprotegerin induces the proliferation of rodent vascular smooth muscle cells both in vitro and in vivo","volume":"47","author":"Candido","year":"2010","journal-title":"J. Vasc. Res."},{"key":"10.1016\/j.bbrc.2011.02.117_b0065","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0006-291X(02)00179-1","article-title":"Osteoprotegerin differentially regulates protease expression in osteoclast cultures","volume":"293","author":"Wittrant","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2011.02.117_b0070","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1097\/01.ASN.0000141960.01035.28","article-title":"Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD","volume":"15","author":"Reynolds","year":"2004","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bbrc.2011.02.117_b0075","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1161\/01.ATV.0000105902.89459.09","article-title":"Expression, regulation, and function of IGF-1, IGF-1R, and IGF-1 binding proteins in blood vessels","volume":"24","author":"Delafontaine","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbrc.2011.02.117_b0080","doi-asserted-by":"crossref","first-page":"15972","DOI":"10.1016\/S0021-9258(17)36354-8","article-title":"Isolation and characterization of calcium-accumulating matrix vesicles from chondrocytes of chicken epiphyseal growth plate cartilage in primary culture","volume":"260","author":"Wuthier","year":"1985","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2011.02.117_b0085","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.1073\/pnas.95.6.3094","article-title":"Chondrocyte-derived apoptotic bodies and calcification of articular cartilage","volume":"95","author":"Hashimoto","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbrc.2011.02.117_b0090","doi-asserted-by":"crossref","first-page":"5117","DOI":"10.1074\/jbc.273.9.5117","article-title":"Characterization of structural domains of human osteoclastogenesis inhibitory factor","volume":"273","author":"Yamaguchi","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2011.02.117_b0095","doi-asserted-by":"crossref","first-page":"17213","DOI":"10.1074\/jbc.M412751200","article-title":"ATP binding regulates oligomerization and endosome association of RME-1 family proteins","volume":"280","author":"Lee","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2011.02.117_b0100","doi-asserted-by":"crossref","first-page":"4104","DOI":"10.1210\/jc.2003-031432","article-title":"Localization of osteoprotegerin, tumor necrosis factor-related apoptosis-inducing ligand, and receptor activator of nuclear factor-kappaB ligand in Monckeberg\u2019s sclerosis and atherosclerosis","volume":"89","author":"Schoppet","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbrc.2011.02.117_b0105","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1161\/01.RES.0000149165.99974.12","article-title":"Regulation of vascular calcification by osteoclast regulatory factors RANKL and osteoprotegerin","volume":"95","author":"Collin-Osdoby","year":"2004","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbrc.2011.02.117_b0110","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s10735-004-3839-1","article-title":"Detection of osteoprotegerin (OPG) and its ligand (RANKL) mRNA and protein in femur and tibia of the rat","volume":"36","author":"Silvestrini","year":"2005","journal-title":"J. Mol. Histol."},{"key":"10.1016\/j.bbrc.2011.02.117_b0115","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1525-139X.2007.00255.x","article-title":"The vascular biology of calcification","volume":"20","author":"Shroff","year":"2007","journal-title":"Semin. Dial."},{"key":"10.1016\/j.bbrc.2011.02.117_b0120","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1681\/ASN.2004100895","article-title":"Multifunctional roles for serum protein fetuin-a in inhibition of human vascular smooth muscle cell calcification","volume":"16","author":"Reynolds","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bbrc.2011.02.117_b0125","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1161\/01.RES.87.11.1055","article-title":"Apoptosis regulates human vascular calcification in vitro: evidence for initiation of vascular calcification by apoptotic bodies","volume":"87","author":"Proudfoot","year":"2000","journal-title":"Circ. Res."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X11003366?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X11003366?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T10:53:07Z","timestamp":1757760787000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X11003366"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["S0006291X11003366"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2011.02.117","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Crystallizing nanoparticles derived from vascular smooth muscle cells contain the calcification inhibitor osteoprotegerin","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2011.02.117","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}